NCT04071366 A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy Status COMPLETED Phase PHASE2
NCT03642626 MT2017-45: CAR-T Cell Therapy for Heme Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE2